Evaluation of the BD bactec MGIT 320 system for detection of mycobacteria and drug susceptibility testing of mycobacterium tuberculosis

7Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Two different laboratories evaluated growth and detection of mycobacteria and drugsusceptibility testing of Mycobacterium tuberculosis by the BD Bactec MGIT 320 using the BD Bactec MGIT 960 (BD Diagnostics, Sparks, MD) as a reference method. Out of 359 processed sputum specimens for detection of mycobacteria, 99.7% were in agreement between the MGIT 320 and MGIT 960. Streptomycin (STR), isoniazid (INH), rifampin (RIF), ethambutol (EMB) (collectively known as SIRE), and pyrazinamide (PZA) drug susceptibility testing was performed on 89 clinical strains, prepared from both liquid and solid inocula. The results of SIRE and PZA were 100% reproducible between the two instruments tested at both laboratories. Copyright © 2013, American Society for Microbiology.

Cite

CITATION STYLE

APA

Duque, A., Grace Lin, S. Y., Desmond, E., Rienthong, S., Rienthong, D., & Boonin, C. (2013). Evaluation of the BD bactec MGIT 320 system for detection of mycobacteria and drug susceptibility testing of mycobacterium tuberculosis. Journal of Clinical Microbiology, 51(10), 3403–3405. https://doi.org/10.1128/JCM.01357-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free